|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2010-7-28
|
|
pubmed:abstractText |
The prognostic role of epidermal growth factor receptor (EGFR) mutations in patients with surgically resectable non-small cell lung cancer (NSCLC) without EGFR tyrosine kinase inhibitor treatment has not been well established, because the reports are still few.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1556-1380
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1175-84
|
|
pubmed:meshHeading |
pubmed-meshheading:20559151-Adenocarcinoma,
pubmed-meshheading:20559151-Aged,
pubmed-meshheading:20559151-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:20559151-Female,
pubmed-meshheading:20559151-Gene Dosage,
pubmed-meshheading:20559151-Humans,
pubmed-meshheading:20559151-Lung Neoplasms,
pubmed-meshheading:20559151-Male,
pubmed-meshheading:20559151-Mutation,
pubmed-meshheading:20559151-Neoplasms, Squamous Cell,
pubmed-meshheading:20559151-Proto-Oncogene Proteins,
pubmed-meshheading:20559151-Receptor, Epidermal Growth Factor,
pubmed-meshheading:20559151-Retrospective Studies,
pubmed-meshheading:20559151-Survival Rate,
pubmed-meshheading:20559151-Taiwan,
pubmed-meshheading:20559151-Treatment Outcome,
pubmed-meshheading:20559151-ras Proteins
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Prognostic implications of epidermal growth factor receptor and KRAS gene mutations and epidermal growth factor receptor gene copy numbers in patients with surgically resectable non-small cell lung cancer in Taiwan.
|
|
pubmed:affiliation |
Department of Cardiovascular and Thoracic Surgery, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, TaoYuan, Taiwan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
